Evidence map›Paper›PMID 42238896›Full record

ArticleIJID regions2026

Factors associated with the treatment success rate among patients with multidrug-resistant tuberculosis at Soroti Regional Referral Hospital, Soroti City: A retrospective cohort study.

Susan Ampumulize, Saadick Mugerwa Ssentongo, Bonniface Oryokot, Hamidah Kakooza Mulungi, James Katerega, Mark Kizito

Abstract read
In one paragraph

Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susan AmpumulizeDepartment of Public Health, School of Health Sciences, Soroti University, Soroti, Uganda.
Saadick Mugerwa SsentongoDirectorate of Program Management and Capacity Development, Baylor College of Medicine Children's Foundation, Kampala, Uganda.
Bonniface OryokotDirectorate of Program Management and Capacity Development, AIDS Information Center, Kampala, Uganda.
Hamidah Kakooza MulungiMbarara Regional Referral Hospital, Ministry of Health, Mbarara city, Uganda.
James KateregaDepartment of Public Health, School of Health Sciences, Soroti University, Soroti, Uganda.
Mark KizitoDepartment of Internal Medicine, School of Health Sciences, Soroti University, Soroti, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To determine the prevalence and factors associated with the treatment success rate (TSR) among patients with multidrug-resistant tuberculosis (MDR-TB). Methods: A retrospective cohort study was conducted among patients with MDR-TB treated at Soroti Regional Referral Hospital from January 2018 to December 2022. A total of 79 patients' files were reviewed, and information was filled in a data abstraction form on treatment success, which was defined as completion and cure after the treatment. A modified Poisson regression was conducted to identify the factors associated with the TSR, with a level of significance set at Results: The TSR was 87.3% (n = 69). Factors significantly associated with low TSR included undernutrition (body mass index <18.5 kg/m Conclusion: Our study identified a low TSR of 87.3% below the World Health Organization target of 90%, which was associated with having anemia and undernutrition. These findings highlight the need to integrate nutrition support and timely management of anemia through blood transfusion and iron supplementation to improve treatment outcomes for MDR-TB.

Indexed as

Multidrug-resistant tuberculosisTreatment success rateUganda

Identifiers

PMID42238896
PMCPMC13226215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.